Cannabis use and risk of testicular germ cell tumour: a systematic review and meta‐analysis
- 4 November 2025
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 137 (1) , 58-65
Abstract
Objectives: To systematically review and analyse the association of cannabis use with the risk of testicular germ cell tumour (TGCT), as studies have implicated an association between cannabis exposure and an increased risk of developing TGCT. Patients and Methods: The PubMed, Web of Science, and Cochrane Library databases were searched on November 2024 to identify eligible studies according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses statement and the Cochrane Handbook for Systematic Reviews of Interventions. Studies were selected that compared males (P: population) who had cannabis use (I: interventions) to non‐users or infrequent users of cannabis (C: comparators) with development of TGCT as the endpoint (O: outcomes) using multivariable analyses that adjusted for the effects of covariates (S: study type). The primary study outcome was the risk of TGCT among cannabis users. Available multivariable odds ratios (ORs) and hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were included in quantitative analysis. Results: A total of 86 articles were identified from our search, of which five were included for qualitative and quantitative analysis. Three studies were case–control and two were cohort in design. Current cannabis use was significantly associated with increased risk of TGCT (OR 1.62, 95% CI 1.13–2.31; P < 0.05 [two studies]), as was long‐term (≥10 years) cannabis use (OR 1.68, 95% CI 1.19–2.36; P < 0.05 [three studies]). In subgroup analysis, ever cannabis use was significantly associated with increased risk of non‐seminomatous germ cell tumour (NSGCT) (OR 1.71, 95% CI 1.12–2.60; P < 0.05 [two studies]). Conclusion: Our findings highlight cannabis use as a significant modifiable risk factor for the development of TGCT, particularly NSGCT. Given the increasing legalisation and availability of cannabis, further research is necessary to explore the underlying biological mechanisms and to confirm these associations across diverse populations.Keywords
This publication has 13 references indexed in Scilit:
- Prevalence of and trends in current cannabis use among US youth and adults, 2013–2022Drug and Alcohol Dependence Reports, 2024
- A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)Environment International, 2024
- European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateEuropean Urology, 2023
- Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobankCancer Medicine, 2022
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistanceExpert Review of Anticancer Therapy, 2020
- Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011Cancer Epidemiology, Biomarkers & Prevention, 2017
- Population‐based case‐control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma riskCancer, 2012
- Marijuana use and testicular germ cell tumorsCancer, 2010
- Association of marijuana use and the incidence of testicular germ cell tumorsCancer, 2009